Compounds > buserelin
Page last updated: 2024-08-23

buserelin and Adenoma

buserelin has been researched along with Adenoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chin, WW; Conn, PM; Kaiser, UB; Katzenellenbogen, RA1
Damjanovic, S; Popovic, V1
Daniels, M; Dunn, J; Kendall-Taylor, P; Newland, P; White, MC1
Claustrat, B; Forest, MG; Lahlou, N; Lejeune, H; Loras, B; Sassolas, G; Trouillas, J1
Farid, NR; Jean, C; Maheux, R; Parent, JG; Samson, Y1

Other Studies

5 other study(ies) available for buserelin and Adenoma

ArticleYear
Evidence that signalling pathways by which thyrotropin-releasing hormone and gonadotropin-releasing hormone act are both common and distinct.
    Molecular endocrinology (Baltimore, Md.), 1994, Volume: 8, Issue:8

    Topics: Adenoma; Animals; Buserelin; Calcium; DNA, Complementary; Gene Expression Regulation; Glycoprotein Hormones, alpha Subunit; Gonadotropin-Releasing Hormone; GTP-Binding Proteins; Luciferases; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoric Diester Hydrolases; Pituitary Neoplasms; Prolactin; Protein Kinase C; Rats; Receptors, LHRH; Receptors, Thyrotropin-Releasing Hormone; Recombinant Fusion Proteins; Signal Transduction; Thyrotropin-Releasing Hormone; Transfection; Tumor Cells, Cultured

1994
The effect of thyrotropin-releasing hormone on gonadotropin and free alpha-subunit secretion in patients with acromegaly and functionless pituitary tumors.
    Thyroid : official journal of the American Thyroid Association, 1998, Volume: 8, Issue:10

    Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Buserelin; Female; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Gonadotropins, Pituitary; Humans; Immunohistochemistry; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Thyrotropin-Releasing Hormone

1998
Long-term effects of a gonadotrophin-releasing hormone agonist ([D-Ser(But)6]GnRH(1-9)nonapeptide-ethylamide) on gonadotrophin secretion from human pituitary gonadotroph cell adenomas in vitro.
    The Journal of endocrinology, 1988, Volume: 118, Issue:3

    Topics: Adenoma; Adult; Aged; Buserelin; Cells, Cultured; Female; Follicle Stimulating Hormone; Glycoprotein Hormones, alpha Subunit; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Hormone-Releasing Hormones; Pituitary Neoplasms; Time Factors

1988
Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
    The Journal of clinical endocrinology and metabolism, 1988, Volume: 67, Issue:1

    Topics: Adenoma; Adult; Buserelin; Drug Evaluation; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Stimulation, Chemical; Testosterone; Time Factors; Triptorelin Pamoate

1988
Utilization of luteinizing hormone-releasing hormone agonist in pulmonary leiomyomatosis.
    Fertility and sterility, 1987, Volume: 48, Issue:2

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Buserelin; Dyspnea; Estradiol; Female; Humans; Leiomyoma; Lung Neoplasms; Ovariectomy; Pain; Uterine Neoplasms

1987